Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
| Data | Nome del titolare | Azioni transazionate | Intervallo di valore ($) | Tipo di transazione | Intervallo di prezzo ($) | Azioni a fine dichiarazione | % di variazione |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Mr. Richard J. EdwardsVP & GM | -455,00 | 262,56k | Sale to Issuer | 571,96 - 578,34 | 10,50k | -4,15% |
| 2026-06-01 | Mr. Robert M. SullivanVP & CFO | -469,00 | 269,98k | Sale to Issuer | 571,96 - 578,34 | 12,78k | -3,54% |
| 2026-06-01 | Dr. Michael J. HartnettChairman, President & CEO | -4,89k | 2,80M | Sale to Issuer | 571,96 | 307,19k | -1,57% |
| 2026-06-01 | Mr. John J. FeeneyVP, General Counsel & Secretary | -131,00 | 75,53k | Sale to Issuer | 571,96 - 578,34 | 2,60k | -4,79% |
| 2026-06-01 | Mr. Daniel A. BergeronVP, COO & Director | -1,63k | 932,29k | Sale to Issuer | 571,96 | 113,82k | -1,41% |
| 2026-06-03 | Mr. Edward D. StewartIndependent Director | -600,00 | 236,20k | Derivative Exercise and Sale | 199,16 - 592,83 | 21,34k | - |
| 2026-06-03 | Mr. Barry C. BoyanDirector | -555,00 | 328,35k | Vendita | 591,63 | 3,75k | -12,89% |
| 2026-05-23 | Mr. Robert M. SullivanVP & CFO | -176,00 | 100,53k | Sale to Issuer | 559,95 - 577,42 | 13,24k | -1,31% |
| 2026-05-23 | Mr. John J. FeeneyVP, General Counsel & Secretary | -58,00 | 32,93k | Sale to Issuer | 559,95 - 577,42 | 2,73k | -2,08% |
| 2026-05-23 | Mr. Richard J. EdwardsVP & GM | -99,00 | 56,36k | Sale to Issuer | 559,95 - 577,42 | 10,95k | -0,90% |
| 2026-05-23 | Mr. Daniel A. BergeronVP, COO & Director | -1,78k | 1,01M | Sale to Issuer | 559,95 - 577,42 | 115,45k | -1,52% |
| 2026-05-23 | Dr. Michael J. HartnettChairman, President & CEO | -2,65k | 1,49M | Sale to Issuer | 559,95 | 312,08k | -0,84% |
| 2025-11-04 | Mr. Richard Ryder CrowellLead Independent Director | -4,70k | 2,01M | Other Disposition | 427,24 | 27,65k | -14,53% |
| 2026-05-19 | Dr. Michael J. HartnettChairman, President & CEO | -10,26k | 5,80M | Sale to Issuer | 565,22 | 314,73k | -3,16% |
| 2026-05-19 | Mr. Daniel A. BergeronVP, COO & Director | -921,00 | 520,57k | Sale to Issuer | 565,22 | 117,24k | -0,78% |
| 2026-02-17 | Mr. Richard J. EdwardsVP & GM | -2,60k | 884,66k | Derivative Exercise and Sale | 199,10 - 554,01 | 11,08k | - |
| 2026-02-17 | Mr. Richard J. EdwardsVP & GM | -1,50k | 830,48k | Vendita | 553,65 | 11,08k | -11,92% |
| 2026-02-08 | Mr. John J. FeeneyVP, General Counsel & Secretary | -34,00 | 18,50k | Sale to Issuer | 544,02 | 2,63k | -1,28% |
| 2025-11-20 | Mr. Barry C. BoyanDirector | -10,00 | 4,30k | Sale to Issuer | 430,24 | 3,96k | -0,25% |
| 2025-11-12 | Dr. Steven H. KaplanIndependent Director | -200,00 | 56,97k | Derivative Exercise and Sale | 158,48 - 443,35 | 2,00k | - |
| 2025-11-12 | Dr. Steven H. KaplanIndependent Director | -500,00 | 221,43k | Vendita | 442,86 | 2,00k | -20,01% |
| 2025-11-07 | Mr. Barry C. BoyanDirector | -1,20k | 358,82k | Derivative Exercise and Sale | 135,53 - 434,55 | 3,97k | - |
| 2025-11-05 | Mr. Robert M. SullivanVP & CFO | -112,00 | 47,85k | Sale to Issuer | 427,24 | 12,19k | -0,91% |
| 2025-09-26 | Mr. John J. FeeneyVP, General Counsel & Secretary | -105,00 | 40,20k | Vendita | 382,83 | 2,67k | -3,79% |
| 2025-09-04 | Mr. Richard Ryder CrowellLead Independent Director | -125,00 | 0,00 | Other Disposition | - | 32,14k | -0,39% |
| 2025-08-07 | Mr. Daniel A. BergeronVP, COO & Director | -48,74k | 11,20M | Derivative Exercise and Sale | 137,44 - 402,75 | 111,13k | - |
| 2025-06-17 | Mr. Michael H. AmbroseInsider | -595,00 | 80,04k | Derivative Exercise and Sale | 206,19 - 367,32 | 6,99k | - |
| 2025-06-17 | Mr. Michael H. AmbroseInsider | -150,00 | 55,06k | Other Disposition | 367,05 | 6,99k | -2,10% |
| 2025-06-11 | Mr. Richard Ryder CrowellLead Independent Director | -500,00 | 115,57k | Derivative Exercise and Sale | 137,44 - 377,00 | 32,27k | - |
| 2025-06-12 | Dr. Michael J. HartnettChairman, President & CEO | -9,00k | 3,34M | Vendita | 371,37 | 302,85k | -2,89% |
| 2025-06-09 | Dr. Michael J. HartnettChairman, President & CEO | -26,98k | 5,64M | Derivative Exercise and Sale | 137,44 - 382,85 | 311,85k | - |
| 2025-06-11 | Dr. Michael J. HartnettChairman, President & CEO | -5,00k | 1,88M | Vendita | 375,00 | 311,85k | -1,58% |
| 2025-06-10 | Mr. Michael H. AmbroseInsider | -1,70k | 346,28k | Derivative Exercise and Sale | 137,44 - 381,05 | 7,14k | - |
| 2025-06-06 | Mr. Daniel A. BergeronVP, COO & Director | -35,00k | 8,28M | Derivative Exercise and Sale | 143,92 - 382,21 | 111,13k | - |
| 2025-06-09 | Dr. Steven H. KaplanIndependent Director | -400,00 | 152,52k | Vendita | 381,30 | 2,50k | -13,80% |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Registrati con e-mail
Hai già un account? Accedi
Non hai un account? Registrati
Registrandomi, confermo di aver letto, capito, e accetto i termini e condizioni ADVFN e che sono un investitore privato.
Caratteristiche principali
Premium
